Movement to Molecular Diagnostics for Infectious Disease

In this episode of NAMSA's MedTech Matters video series, Mark Boyle (Vice President of Global Consulting Services at NAMSA) discusses a key trend in the In Vitro Diagnostic (IVD) market–the movement towards molecular diagnostics, particularly over-the-counter and point-of-care diagnostics. He touches on the manufacturer considerations for products within this category, such as having a sound commercial plan in place, a good understanding of the market, and a good grasp of the current regulatory landscape, and how NAMSA can assist clients with this process.

To learn about how NAMSA's IVD Consulting Services can accelerate your timelines, please visit: https://namsa.com/services/ivd/

Schedule a complimentary consultation with our global experts at: https://namsa.com/namsa-expertise/sub...